Log in to save to my catalogue

Efficacy of the novel tubulin polymerization inhibitor PTC‐028 for myelodysplastic syndrome

Efficacy of the novel tubulin polymerization inhibitor PTC‐028 for myelodysplastic syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7734154

Efficacy of the novel tubulin polymerization inhibitor PTC‐028 for myelodysplastic syndrome

About this item

Full title

Efficacy of the novel tubulin polymerization inhibitor PTC‐028 for myelodysplastic syndrome

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2020-12, Vol.111 (12), p.4336-4347

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Monomer tubulin polymerize into microtubules, which are highly dynamic and play a critical role in mitosis. Therefore, microtubule dynamics are an important target for anticancer drugs. The inhibition of tubulin polymerization or depolymerization was previously targeted and exhibited efficacy against solid tumors. The novel small molecule PTC596 di...

Alternative Titles

Full title

Efficacy of the novel tubulin polymerization inhibitor PTC‐028 for myelodysplastic syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7734154

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7734154

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.14684

How to access this item